[at Motley Fool] – This disease takes the lives of more Americans than any other. It’s not HIV/AIDS and not hepatitis C, but Gilead Sciences is taking the disease head on.
Read more on this.
Gilead Sciences Inc. (GILD), valued … [visit site to read more]
Similar posts:- Market Update on Gilead Sciences Inc. (NASDAQ:GILD) – Gilead Sciences Expections Down [at Forbes] – Gilead Sciences reports its third quarter...
- Gilead Sciences Inc. (NASDAQ:GILD) – Gilead’s Hepatitis C Pill Works Better, FDA Report Says [at Bloomberg] – Gilead Sciences Inc.’s experimental hepatitis C...
- Surface RT recovery image released to fix Windows RT 8.1 update issues – Microsoft Corporation (NYSE:MSFT) [at The Verge] – Microsoft is releasing a Surface...